Loading insider details...
Beta
Latest Form 4 (Aug 21, 2026): Grant/Award of 1,345,500 HEPA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/Award | 1,345,500 | n/a |
| Aug 13, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 2,000,000 | $100.0K |
| May 27, 2026 | Canton Strategic Holdings, Inc. (CNTN) | Sale | 10,000 | $34.5K |
| Apr 27, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 1,250,000 | $50.0K |
| Nov 6, 2025 | Tharimmune, Inc. (THAR) | Grant/Award | 32,500 | n/a |